Literature DB >> 18209035

Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing.

Jens Hänig1, Manfred B Lutz.   

Abstract

The priming of CD4+ effector T cells (T(eff)) in vivo is induced by mature dendritic cells (DC) and controlled by CD4+CD25+Foxp3+ regulatory T cells (T(reg)). It remains unclear,however, how T(eff) priming vs T(reg) suppression are regulated during Ag presentation by DC in secondary lymphoid organs at the simultaneous presence of T(eff) and T(reg). In this study, we used an peptide-specific DO11.10 TCR-transgenic adoptive transfer model to follow the T(eff) priming kinetics and the mechanisms of suppression by T(reg). T(reg) activation was slower as compared with T(eff) and could not influence the early T(eff) expansion but limited the T(eff) response leading to lower T(eff) numbers in the memory phase. DC-T(reg) cell contacts remained unaltered during suppression by T(reg) and led to a down-regulation of the costimulatory molecules CD80, CD86, PD-L1, and PD-L2 but not MHC II, CD40, ICOS-L, or CD70 from the mature DC surface. This effect was observed only after DC maturation with TNF or LPS but not after additional CD40 licensing. Together, our data indicate that T(reg) suppression against nonself Ags in vivo occurs delayed due to the slower T(reg) response, is mediated to a large extent through DC modulation, but is controlled by the type of DC maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209035     DOI: 10.4049/jimmunol.180.3.1405

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

2.  Tolerance induced by anti-DNA Ig peptide in (NZB×NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells.

Authors:  Yiyun Yu; Yaoyang Liu; Fu-Dong Shi; Hejian Zou; Bevra H Hahn; Antonio La Cava
Journal:  Clin Immunol       Date:  2011-11-15       Impact factor: 3.969

Review 3.  Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation.

Authors:  Kate S Smigiel; Shivani Srivastava; J Michael Stolley; Daniel J Campbell
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

4.  T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow.

Authors:  Arielle Glatman Zaretsky; Christoph Konradt; Fabien Dépis; James B Wing; Radhika Goenka; Daniela Gomez Atria; Jonathan S Silver; Sunglim Cho; Amaya I Wolf; William J Quinn; Julie B Engiles; Dorothy C Brown; Daniel Beiting; Jan Erikson; David Allman; Michael P Cancro; Shimon Sakaguchi; Li-Fan Lu; Christophe O Benoist; Christopher A Hunter
Journal:  Cell Rep       Date:  2017-02-21       Impact factor: 9.423

5.  The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells.

Authors:  Tessy Iype; Mohan Sankarshanan; Ileana S Mauldin; David W Mullins; Ulrike Lorenz
Journal:  J Immunol       Date:  2010-10-15       Impact factor: 5.422

6.  PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.

Authors:  Wenshi Wang; Roy Lau; Daohai Yu; Weiwei Zhu; Alan Korman; Jeffrey Weber
Journal:  Int Immunol       Date:  2009-08-03       Impact factor: 4.823

Review 7.  Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

Authors:  Sébastien André; David F Tough; Sébastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

8.  Tumor regulatory T cells potently abrogate antitumor immunity.

Authors:  Zuqiang Liu; Jin H Kim; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination.

Authors:  Taylor H Schreiber; Dietlinde Wolf; Maria Bodero; Eckhard Podack
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

10.  Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo.

Authors:  Anna Sophie Thomann; Theresa Schneider; Laura Cyran; Ina Nathalie Eckert; Andreas Kerstan; Manfred B Lutz
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.